PAMG
DGX icon

Patton Albertson Miller Group’s Quest Diagnostics DGX Stock Holding History

Patton Albertson Miller Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-150
Closed -$14K – 160
2018
Q3 		$14K Buy
+150
New +$16.5K 0.01% 229
2014
Q1 		– Sell
-7,275
Closed -$390K – 158
2013
Q4 		$390K Sell
7,275
-6,175
-46% -$366K 0.23% 97
2013
Q3 		$831K Buy
13,450
+175
+1% +$10.5K 0.49% 66
2013
Q2 		$805K Buy
+13,275
New +$791K 0.49% 65

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Patton Albertson Miller Group's DGX Position: Q4 2018 in Review

Patton Albertson Miller Group sold out of Quest Diagnostics (DGX) in Q4 2018, closing a stake of 150 shares — an estimated $14K sold.

Patton Albertson Miller Group first reported a position in DGX in Q2 2013 and held it in 4 quarters. The position peaked at $831K in Q3 2013. 624 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

  • Patton Albertson Miller Group reported no remaining Quest Diagnostics position as of Q4 2018 after selling out during the quarter.
  • Patton Albertson Miller Group sold 150 Quest Diagnostics shares in Q4 2018, an estimated $14K.
  • Patton Albertson Miller Group first reported a position in Quest Diagnostics in Q2 2013 and held it in 4 quarters.
  • Patton Albertson Miller Group's Quest Diagnostics position peaked at $831K in Q3 2013.
  • 624 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on Patton Albertson Miller Group's 13F filing for Q4 2018, filed 12 Feb 2019.